Position in ADCT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$29,325
-$27,430 QoQ
Shares Held
27,407
+70.5% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 113 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $9,179,081 across 16 Drug Manufacturers - Specialty & Generic names. ADCT ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
41,355 | $2,971,770 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
50,448 | $1,241,525 | |
| 3 | VTRS |
Viatris Inc
|
76,086 | $1,208,245 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
23,376 | $959,117 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
12,095 | $571,730 | |
| 6 | LQDA |
Liquidia Corp
|
6,846 | $545,831 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
54,534 | $545,340 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
9,572 | $242,841 |
All Filings in ADCT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,325 | 27,407 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $56,755 | 16,078 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||